From our unique state-of-the-art platform for development and scale-up of Oligonucleotides and Peptides in Frankfurt (Germany), CEPiA offers customized services (manufacturing and analytical) and can provide the full scope of development activities from clinical phase up to submission and launch, including regulatory support, as well as commercial supplies.
Both sites are regularly inspected by FDA, International and European agencies.
In Frankfurt, cGMP API manufacturing can be combined with Drug Product and Devices Technology (Fill & Finish on our « TIDES » platform).
Through Sanofi’s 25-years-experience in the field of oligonucleotides, CEPiA can provide different classes of Oligonucleotides such as DNA, 2’-O-Modified, Phosphorothioate derivatives via solid phase chemistry.
CEPiA can develop your Oligonucleotides from g scale up to kg quantities. ...